HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 1 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,127,941 | +12.5% | 78,900 | 0.0% | 3.05% | +19.7% |
| Q2 2023 | $8,114,865 | -5.8% | 78,900 | 0.0% | 2.54% | -26.7% |
| Q1 2023 | $8,611,146 | -4.1% | 78,900 | 0.0% | 3.47% | +3.4% |
| Q4 2022 | $8,978,820 | +83.9% | 78,900 | 0.0% | 3.36% | +89.8% |
| Q3 2022 | $4,883,000 | +10.5% | 78,900 | +42.4% | 1.77% | +5.6% |
| Q2 2022 | $4,419,000 | – | 55,400 | – | 1.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 546,775 | $50,325,000 | 22.36% |
| Paulson & Co. | 7,991,440 | $735,532,000 | 16.89% |
| Avoro Capital Advisors LLC | 9,000,000 | $828,360,000 | 14.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 393,000 | $36,176,000 | 9.57% |
| Tri Locum Partners LP | 293,426 | $27,007,000 | 6.70% |
| 1492 Capital Management LLC | 237,422 | $21,852,000 | 6.28% |
| Iron Triangle Partners LP | 500,000 | $46,020,000 | 5.85% |
| HealthCor Management, L.P. | 1,725,650 | $158,829,000 | 5.62% |
| Eversept Partners, LP | 695,459 | $64,010,046 | 4.81% |
| PFM Health Sciences, LP | 1,587,348 | $146,100,000 | 4.46% |